10x Genomics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-17.9M | $-13.5M | $-16.3M | $-27.5M | $34.5M | $-34.4M | $-49.0M | $-35.8M |
| Depreciation & Amortization | $9.7M | $10.0M | $10.1M | $10.3M | $7.8M | $8.0M | $8.8M | $9.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $25.6M | $22.6M | $25.2M | $25.3M | $27.6M | $31.1M | $32.5M | $33.6M |
| Net Cash from Operating Activities | $17.0M | $26.1M | $40.8M | $43.2M | $17.7M | $34.4M | $-6.7M | $21.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.6M | $1.6M | $1.8M | $687.0K | $1.6M | $1.9M | $2.7M | $3.9M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-7.7M | $-1.3M | $-1.8M | $-8.8M | $-939.0K | $-1.9M | $-51.6M | $-3.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $3.0M | $-8.4M | $2.2M | $617.0K | $3.5M | $422.0K | $4.5M | $156.0K |
| Net Change in Cash | $12.2M | $16.3M | $41.3M | $35.0M | $20.7M | $33.0M | $-54.1M | $18.3M |
| Free Cash Flow | $15.4M | $24.5M | $39.0M | $42.5M | $16.1M | $32.5M | $-9.5M | $17.8M |